The Hep3B survival rates detected by MTT assay were 73% with rAdV-p53 and rAdV-TK/GCV, and 45% following rAdV-p53, rAdV-ASPP2 and rAdV-TK/GCV co-infection. This evidence concerns the gene TP53BP2 and coinfection.